Quality, clinical effectivity and harmonisation of POCT

Authors: B. Friedecký 1,2;  J. Kratochvíla 1
Authors‘ workplace: SEKK s. r. o. Pardubice 1;  ÚKBD FN Hradec Králové 2
Published in: Klin. Biochem. Metab., 27, 2019, No. 1, p. 19-24


Communication deals with some aspects of POCT testing by means of recent literature and by following comparison of conditions in Czech Republic and other countries. Increased attention is devoted to external quality assessment programs. In Czech Republic is not in this time sufficiently developed study of POCT testing. Generally, is possible to observe the lack of data from POCT studies on the patient’s outcomes. This may be serious obstacle for positive value and real advantage of POCT- shortening of turn-around-time.


POCT – external quality assessment – trends of future development – clinical outcomes – EHK


1. Kolektiv autorů: Metrologická terminologie ve zdravotnické a analytické laboratoři 3. 2018. Dostupné na: http://www.sekk.cz/terminologie/index.php

2. Stavelin, A., Sandberg, S. Harmonization activities of Noklus-a quality improvement organization for point-of-care laboratory examination. Clin. Chem. Lab. Med., 2019, 57/1, p. 106-114.

3. Wiencek, J., Nichols, J. Issues in the practical implementation of POCT: overcoming challenges. Expert Rev. Mol. Diagn., 2016, 16/4, p. 415-422.

4. Stavelin, A., Petersen, P. H., Solvik, U. O., Sandberg, S. External quality assessment of method: model for combinated assessment of method bias and single-participant performance by the use of native patient samples and noncommutable control materials. Clin. Chem., 2013, 59/2, p. 363-371.

5. Vassault, A. Definition of EQAS Allovable Limits for Hba1c: A Candidate Method. EQALM Symposium Dublin, October 2017 (http://www.eqalm.org/site/index.php).

6. Weykamp, C. et al. EurA1c: the European HbA1c trial to investigate the performance of HbA1c assays in 2166 laboratories across 17 countries and 24 manufacturers by use of the IFCC model for quality targets. Clin. Chem., 2018, 56/8, p. 1183-1193.

7. Nordin, G. Accuracy of HbA1c as monitored by external assessment and compared with patient mean values. J Diabet. Sci. Technol., 2018,14/2, p. 771-779.

8. Spaeth, B. A., Shephard, M., Schatz, S. Point-of-care testing for hemoglobin A1c in rural Australian indigenous communities improves timeliness of diabetes care. Rural Remote Health, 2014,14/4, p. 2849.

9. English, E., Lenters-Westra, E. HbA1c method performance: The great success story of global standardization. Crit. Rev. Clin. Lab. Sci., 2018, 55/6, p. 408-419.

10. Bowman, C., Cunningham, S. IFCC WG GMECC: How should glucose meters be evaluated in critical care. eNews IFCC April 2018.

11. ČSN EN ISO 15197:2016 ed.: Systémy diagnostických zkoušek in vitro - Požadavky na systémy monitorování glykémie pro sebetestování pacientů s diabetes mellitus. In vitro diagnostic test systems - Requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus. (ÚNMZ-ČAS 2017).

12. Bietenbeck, A., Geilenkeuser, W. J., Klawonn, F., Spannagl, M., Nauck, M., Petersmann, A. et al External quality assessment schemes for glucose measurements in Germany: Factors for successful participation, analytical performance and medical impact. Clin. Chem. Lab. Med., 2018, 56/8, p. 1238-1250.

13. Wang, P., Kricka, L. J. Current and emerging trends in point-of-care technology and strategies for clinical validation and implementation. Clin. Chem., 2018, 64/10, p. 1439-1452.

14. ČSN EN ISO 22870:2017. Vyšetření u pacienta (VUP) - Požadavky na kvalitu a způsobilost. Point-of-care testing (POCT) -- Requirements for quality and competence. (ÚNMZ-ČAS 2017).

15. Fonjungo, P. N., Osmanov, S., Kuritski, J., Ndihokubwayo, J. B., Bachanas, P., Peeling, R. W. et al.: Ensuring Quality: A key consideration in scaling-up HIV-related point-of-care testing programs. AIDS 2016,15/8, p. 1317-1323.

16. Fonjungo, P. N., Alemnji, G. A., Kebede, Y., Opio, A., Mvangi, C., Spira, T. J. et al. Combatting global infectious diseases: A network effect of specimen referral systems. Clin. Infect. Dis., 2017, 64, p. 796-803.

17. De Vries, C., Doggen, C., Hilbers, E., Verkeij, R., Ijezerman, M., Geertsma, R. Results of a survey among GP practices on how they manage patient safety aspects related to point-of-care testing in every day practice. BMC Farm. Pract., 2015,16, doi:10.1186/s12875-014-0217-2.

18. Li, L., Mc Caughey, E., Iles-Mann, J., Sergeant, A., Dahm, M. R., Mumford, V. et al. Assessing data integration and quality for the evaluation of point-of-care testing across rural and remote emergency departments in Australia. Stud. Health Technol. Inform., 2017, 245, 471-475.

19. Florkowski, C., Don Wauchope, A., Gimenez, N., Rodriguez-Capote, K., Wils, J., Zemlin, A. Point-of-care testing (POCT) and evidence-based laboratory medicine (EBLM) does it leverage any advantage in clinical decision making? Crit. Rev. Clin. Lab. Sci., 2017, 54, p. 471-494.

20. Pecoraro, V., Germagnoli, L., Banfi, G. Point-of-care testing. Where is the evidence? A systematic survey. Clin. Chem. Lab. Med., 2014, 52, p. 313-324.

21. Larsson, A., Greig-Pylypczuk, R., Huijsman, A. The state of point-care testing: a European perspective. Ups. J Med. Sci., 2015,120/1, p. 1-10.

22. Pecoraro, V., Banfi, G., Germagnoli, L., Trenti, T. A systematic evaluation of immunoassay point-of-care testing to define impact on patients´ outcomes. Ann. Clin. Biochem., 2017, 54, p. 420-431.

23. Sneith, B., Harris, M. A., Skinkins, B., Jordaan, M., Messenger, M., Lewington, A. Point-of-care creatinine testing for kidney function measurement prior to contrast-enhanced diagnostic imaging: evaluation of the performance of three systems for clinical utility. Clin. Chem. Lab. Med., 2018, 56/8, p. 1269-1276.

Clinical biochemistry Nuclear medicine Nutritive therapist
Forgotten password

Don‘t have an account?  Create new account

Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.


Don‘t have an account?  Create new account